• Home
  • Stocks
  • Akums Drugs & Pharmaceuticals Fundamental Analysis
  • Akums Drugs & Pharmaceuticals Fundamental Analysis

Akums Drugs & Pharmaceuticals fundamental analysis

AKUMS

HealthcareMid

445.15

10.35 (2.38%)
Last updated on 1 Feb, 2026 | 15:30 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Akums Drugs & Pharmaceuticals Fundamentals

P/E Ratio

21.85

P/B Ratio

2.2

Div. Yield

0

Sector P/E

65.25

Sector P/B

1.2

Sec. Div. Yield

0.58

Akums Drugs & Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 21.85, compared to the sector average of 65.25. Its P/B Ratio stands at 2.2, while the sector’s is 1.2. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.58%.

Akums Drugs & Pharmaceuticals Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Poor

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Poor

On its scorecard, Akums Drugs & Pharmaceuticals reflects: Price – Expensive, Growth – Poor, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.